Related Experiment Video
Updated: Mar 19, 2026
08:57
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
2.8K
Sarcoma-like tumor originating from oligodendroglioma.
Takuhiro Shoji1, Ryuta Saito2, Masayuki Kanamori1
1Department of Neurosurgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Brain Tumor Pathology
|June 24, 2016
Summary
A rare sarcoma developed at a resected oligodendroglioma site without prior treatment. Genetic analysis suggests a single tumor origin, indicating a novel pathway for sarcoma development post-glioma resection.
Area of Science:
- Neuro-oncology
- Surgical Pathology
- Cancer Genetics
Background:
- Oligosarcoma development at resection sites of oligodendroglioma is rare.
- Sarcomatous lesions post-radiotherapy for gliomas are documented, but spontaneous occurrence without prior treatment is exceptionally uncommon.
- Development of sarcoma without oligodendroglial components at a prior oligodendroglioma site has not been previously reported.
Observation:
- A patient developed a sarcoma at the site of a previously resected oligodendroglioma.
- No history of radiotherapy or chemotherapy preceded the sarcoma development.
- The patient's initial and subsequent tumors exhibited 1p/19q co-deletion and mutated isocitrate dehydrogenase 1.
Findings:
- Fluorescent in situ hybridization confirmed 1p/19q co-deletion in both the oligodendroglioma and the subsequent sarcoma.
- Immunohistochemistry revealed mutated isocitrate dehydrogenase 1 (IDH1) in both tumor types.
- The shared genetic markers (1p/19q co-deletion and IDH1 mutation) strongly suggest a monoclonal origin for both tumors.
Implications:
- This case presents a unique instance of sarcoma arising at a glioma resection site without prior adjuvant therapy.
- The findings suggest a potential new mechanism for the development of sarcomatous lesions originating from residual or recurrent glioma.
- Further research into the molecular pathways driving such transformations could inform future therapeutic strategies for glioma and sarcoma patients.
